10-Q: NorthView Acquisition Corp. Reports Net Loss Amidst Business Combination Efforts and Nasdaq Compliance Challenges

NorthView Acquisition Corp. reports a net loss for the quarter ended September 30, 2024, while navigating a proposed merger with Profusa and ongoing Nasdaq listing compliance issues.

Summary

• NorthView Acquisition Corp., a blank check company, reported a net loss of $1,126,587 for the nine months ended September 30, 2024, compared to a net income of $925,939 for the same period in 2023.
• The company's operating costs were $1,041,241 for the nine months ended September 30, 2024, and $1,048,525 for the same period in 2023.
• The company experienced a loss of $496,020 due to changes in the fair value of warrant liabilities for the nine months ended September 30, 2024.
• Interest income from the Trust Account was $333,934 for the nine months ended September 30, 2024, a significant decrease from $2,103,111 in the same period of 2023.
• The company has extended its business combination deadline to March 22, 2025, and has been making monthly contributions to maintain the trust account.
• NorthView is facing potential delisting from Nasdaq due to non-compliance with listing rules, including the failure to file timely quarterly reports.
• The company has a working capital deficit of $4,483,517 as of September 30, 2024, and has raised funds through a convertible promissory note with its sponsor.
• The company has a convertible promissory note outstanding with a fair value of $1,591,380 as of September 30, 2024.
• The company has recorded an excise tax liability of $1,880,944 due to the redemption of shares.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to the company's net loss, working capital deficit, Nasdaq delisting risk, and uncertainty about completing the business combination. The company's reliance on related party funding and the excise tax liability further contribute to the negative sentiment.

Positives

• The company has extended its business combination deadline to March 22, 2025, providing more time to complete a transaction.
• The company has secured funding through a convertible promissory note with its sponsor, providing additional working capital.
• The company has been granted exceptions by Nasdaq to regain compliance with listing rules, allowing it to remain listed while it addresses the issues.

Negatives

• The company reported a net loss of $1,126,587 for the nine months ended September 30, 2024.
• The company has a significant working capital deficit of $4,483,517 as of September 30, 2024.
• The company is facing potential delisting from Nasdaq due to non-compliance with listing rules.
• Interest income from the Trust Account has decreased significantly compared to the previous year.
• The company has recorded a substantial excise tax liability of $1,880,944 due to share redemptions.

Risks

• The company faces the risk of delisting from Nasdaq if it fails to regain compliance with listing rules.
• The company's ability to complete a business combination by March 22, 2025, is uncertain.
• The company's working capital deficit raises substantial doubt about its ability to continue as a going concern.
• The company is subject to a 1% excise tax on share repurchases, which could reduce available cash.
• The company's financial results are significantly impacted by changes in the fair value of warrant liabilities and convertible notes.

Future Outlook

The company is focused on completing its business combination with Profusa by March 22, 2025, while also addressing its Nasdaq listing compliance issues. The company's ability to continue as a going concern is dependent on completing the business combination.

Management Comments

• Management has determined that mandatory liquidation, and subsequent dissolution, should the Company be unable to complete a business combination, raises substantial doubt about the Companys ability to continue as a going concern for the next twelve months from the issuance of these condensed consolidated financial statements.
• Management has concluded that our disclosure controls and procedures were not effective as of September 30, 2024 due to the existence of material weaknesses related to complex financial instruments specifically related to recording the value of the convertible promissory note, proper recording of accounts payable and accrued expenses, expensing of prepaid expenses and the calculation of the Companys income tax provision.

Industry Context

The report reflects the challenges faced by many SPACs in the current market, including difficulties in completing business combinations and maintaining listing compliance. The company's struggles highlight the risks associated with the SPAC structure and the importance of effective financial controls.

Comparison to Industry Standards

• The company's financial performance is below average compared to other SPACs, particularly in terms of profitability and cash flow.
• The company's operating costs are relatively high for a blank check company, indicating potential inefficiencies.
• The company's reliance on a convertible promissory note from its sponsor is not uncommon for SPACs, but it also highlights the company's limited access to external financing.
• The company's challenges with Nasdaq listing compliance are not unique, as many SPACs have faced similar issues due to the complex regulatory environment.
• The company's excise tax liability is a common issue for SPACs that have conducted share redemptions, reflecting the impact of the Inflation Reduction Act of 2022.

Related Party Transactions

• The company has a convertible promissory note with its sponsor, with a fair value of $1,591,380 as of September 30, 2024.
• The company has a related party loan of $50,000 due to the sponsor for administrative services.
• The company has received advances from Profusa to cover operating expenses, with $320,717 owed as of September 30, 2024.

Stakeholder Impact

• Shareholders face the risk of delisting and potential loss of investment if the company fails to complete a business combination or regain Nasdaq compliance.
• Employees may experience uncertainty about the company's future due to the financial challenges and potential delisting.
• Customers and suppliers of the target company, Profusa, may be impacted by the uncertainty surrounding the merger.
• Creditors of the company face the risk of non-payment if the company is unable to complete a business combination and is forced to liquidate.

Next Steps

• The company must complete its business combination with Profusa by March 22, 2025.
• The company must submit a plan to Nasdaq to regain compliance with listing rules.
• The company must address its working capital deficit and secure additional funding if needed.
• The company must evaluate its options with respect to the excise tax obligation.

Key Dates

Keywords

Business Combination, SPAC, Merger, Nasdaq, Delisting, Warrant Liabilities, Convertible Promissory Note, Excise Tax, Redemption, Trust Account